Manifold MarketsNo KYCVerified resolution dataFairly calibratedData quality warningSource data degraded
Data as of Oct 26, 2026, 5:51 AM UTC · policy pm-quality-4
Current community forecastNo 90.8%
Forecasters
16
Question type
binary
Methodology
Play-money forecasting platform
Source type
Forecast
Market data
Updated 10 hours ago
StaleFeb 21, 23, 8:26 PM UTCDec 31, 27, 10:59 PM UTC
Trends
Related Markets
Related questions for context, not a comparison of equivalent contracts.
Will FDA approve any mRNA vaccine against melanoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028?
Manifold MarketsAny vaccine against Alzheimer's disease to be safe and effective by the end of 2027?
FutuurWill the FDA approve intismeran autogene (V940/mRNA-4157)?
KalshiRules
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of malaria in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
